COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff as we address the COVID-19 situation. Learn more about COVID-19 online education, resources, and live course cancellations through December 31, 2020.

Mayo Clinic COVID-19 Live Webinar Series - June 16, 2020 - ZOOM Webinar

June 16, 2020

The period in which learners can self-claim credit has expired for this course. Please contact us for assistance. Thank you for your understanding.

Session 3: COVID-19 and Pediatric Patients
June 16, 2020 at 9:00 a.m. CT

Despite the rapidly evolving body of data on SARS-CoV-2 and COVID-19, some uncertainty persists around how the virus affects children. In this webinar, Mayo Clinic pediatrics experts will review the latest research, discuss clinical updates and offer guidance for pediatric health care providers.

  • Moderator: W. Charles Huskins, M.D., Chair, Division of Pediatric Infectious Diseases
  • Featured Expert: Rana Chakraborty, M.D., D.Phil., Senior Associate Consultant, Pediatric Infectious Diseases and Immunology
  • Featured Expert: David (DJ) J. Hall, M.D., Chair, Division of Pediatric Hospital Medicine
  • Featured Expert: Emily R. Levy, M.D., Assistant Professor, Pediatric Infectious Diseases and Pediatric Critical Care Medicine
  • Featured Expert: Nipunie S. Rajapakse, M.D., M.P.H., Consultant, Pediatric Infectious Diseases

The views and perspectives shared in these resources are presented based on information available at the time of recording.

Learning Objectives

Upon completion of the Mayo Clinic COVID-19 Live Webinar Series course, learners should be able to:

  • Discuss current research initiatives related to the COVID-19 pandemic
  • Identify promising innovative solutions for treatment strategies in COVID-19 patients
  • Describe the expedited translational research related to COVID-19
  • Describe innovative practice redesign principles to treat patients in a virtual setting.

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
Event starts: 
06/16/2020 - 9:00am
Event ends: 
06/16/2020 - 10:00am

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Financial relationship(s):
W. Charles Huskins, M.D.
ADMA Biologics; Pfizer

No Financial relationship(s):
Barbara L. Baasch Thomas
Mitchell R. Humphreys, M.D.
Jennifer Curran, M.A.
David (DJ) Hall, M.D.
Rana Chakraborty, M.D., D.Phil.
Nipunie S. Rajapakse, M.D., M.P.H
Emily R. Levy, M.D.

Reference to off-label usage(s) of pharmaceuticals or instruments in their presentation:
Emily Levy, M.D.                                 
Gilead / Remdesivir, Various/Convalescent Plasma, Genentech/Tocilizumab, Biovitrum/Anakinra

Nipunie S. Rajapakse, M.D., M.P.H
Gilead, Genentech, Swedish Orphan Biovitrum, Various

Rana Chakraborty, M.D., D.Phil.
Gilead, Remdesivir in children

W. Charles Huskins, M.D.
Gilead, remdesivir / convalescent plasma

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Statements: 

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
 

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Attendance
Please login or register to take this course.

 

If you attended the June 16 webinar and would like to claim credit, please Contact Us.


 Notify me for future live webinars


Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.